cdaa has been researched along with Cirrhosis, Liver in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 7 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akahane, T; Enomoto, M; Fujimoto, Y; Fujinaga, Y; Kaji, K; Kawaratani, H; Murata, K; Namisaki, T; Nishimura, N; Takaya, H; Takeda, S; Tsuji, Y; Yoshiji, H | 1 |
| Barbes, D; Bertotti, K; Huang, P; Julé, Y; Leclercq, IA; Lepoivre, B; Popov, YV; Serdjebi, C; Skelton-Badlani, D; Wei, G | 1 |
| Fábián, A; Ferdinandy, P; Gergely, TG; Kovács, A; Kovács, T; Kucsera, D; Merkely, B; Radovits, T; Ruppert, M; Sayour, NV; Tóth, VE; Varga, ZV | 1 |
| Beyoğlu, D; Huang, P; Idle, JR; Popov, YV; Skelton-Badlani, D; Zong, C | 1 |
| Feldstein, AE; Kaufmann, B; Kim, AD; Kim, SE; Kui, L; Leszczynska, A | 1 |
| Dormann, C; Géraud, C; Krzistetzko, J; Leibing, T; Riedel, A | 1 |
| Abe, A; Miyajima, K; Nakae, D; Nakane, S; Suzuki-Kemuriyama, N; Yuki, M | 1 |
7 other study(ies) available for cdaa and Cirrhosis, Liver
| Article | Year |
|---|---|
Rifaximin and lubiprostone mitigate liver fibrosis development by repairing gut barrier function in diet-induced rat steatohepatitis.
Topics: Acetamides; Amino Acids; Animals; Caco-2 Cells; Chloride Channels; Choline; Diet; Humans; Lipopolysaccharides; Liver; Liver Cirrhosis; Lubiprostone; Neuraminidase; Non-alcoholic Fatty Liver Disease; Pregnane X Receptor; Rats; Rats, Inbred F344; Rifaximin; Tight Junction Proteins; Toll-Like Receptor 4 | 2022 |
Automated whole slide image analysis for a translational quantification of liver fibrosis.
Topics: Animals; Collagen; Fibrosis; Hydroxyproline; Liver; Liver Cirrhosis; Mice | 2022 |
IL-1β neutralization prevents diastolic dysfunction development, but lacks hepatoprotective effect in an aged mouse model of NASH.
Topics: Animals; Disease Models, Animal; Fibrosis; Interleukin-1beta; Liver; Liver Cirrhosis; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease | 2023 |
Metabolic Hijacking of Hexose Metabolism to Ascorbate Synthesis Is the Unifying Biochemical Basis of Murine Liver Fibrosis.
Topics: Aldehyde Reductase; Animals; Ascorbic Acid; Collagen; Diet, High-Fat; Fructose; Galactose; Glucose; Glucuronates; Liver Cirrhosis; Male; Mice; Mice, Inbred C57BL | 2023 |
Myeloid-specific deletion of chitinase-3-like 1 protein ameliorates murine diet-induced steatohepatitis progression.
Topics: Animals; Chitinases; Diet, High-Fat; Disease Models, Animal; Humans; Interleukin-13 Receptor alpha2 Subunit; Liver; Liver Cirrhosis; Mice; Mice, Inbred C57BL; Mice, Knockout; Non-alcoholic Fatty Liver Disease | 2023 |
Association of Differentially Altered Liver Fibrosis with Deposition of TGFBi in Stabilin-Deficient Mice.
Topics: Animals; Cell Adhesion Molecules, Neuronal; Choline; Endothelial Cells; Ligands; Liver; Liver Cirrhosis; Methionine; Mice; Mice, Inbred C57BL; Transforming Growth Factors | 2023 |
Nonalcoholic steatohepatitis-associated hepatocarcinogenesis in mice fed a modified choline-deficient, methionine-lowered, L-amino acid-defined diet and the role of signal changes.
Topics: Amino Acids; Animals; Carcinoma, Hepatocellular; Cell Transformation, Neoplastic; Choline; Choline Deficiency; Diet, High-Fat; Disease Models, Animal; Fibrosis; Interleukin-8; Liver; Liver Cirrhosis; Liver Neoplasms; Methionine; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease | 2023 |